Abstract
Tumour necrosis factor-α (TNF-α) levels were measured in supernatants of macrophage cultures infected in vitro with feline leukaemia virus (FeLV) and in serum, bone marrow plasma, and supernatants of bone marrow mononuclear cell (BMMC) cultures from cats infected with an anemogenic strain of FeLV. TNF-α levels significantly increased (p < 0.05) in the supernatants of in vitro FeLV-infected macrophage cultures compared with uninfected cultures. TNF-α levels in serum and culture supernatants of BMMC from FeLV-infected cats were also significantly increased (p < 0.05) compared with baseline values. Pentoxifylline is a dimethylxanthine derivative that inhibits TNF-α production. Pentoxifylline treatment of FeLV-infected macrophage cultures caused a significant decrease in TNF-α levels. Pentoxifylline given orally to FeLV-infected cats from week 0 to week 5 post-inoculation did not cause significant inhibition of TNF-α levels. Although a trend toward higher numbers of erythroid and fibroblast progenitors was observed in pentoxifylline-treated cats, the changes were not significantly different. The persistent increase in TNF-α levels in serum and culture supernatants of BMMC from FeLV-infected cats suggests that TNF-α may be important in the pathogenesis of hematopoietic suppression.
Similar content being viewed by others
References
Abkowitz JL, Ott RL, Holly RD et al. (1987) Lymphocytes and antibody in retroviras-induced feline pure red cell aplasia. J Natl Cancer Inst 78:135–139
Aggarwal BB, Kohr WJ, Hass PE et al. (1989) Human tumor necrosis factor: production, purification, and characterization. J Biol Chem 260:2345–2351
Boyce JT, Hoover EA, Kociba GJ et al. (1981) Feline leukemia virus induced erythroid aplasia: in vitro hematopoietic culture studies. Exp Hematol 9:990–1001
Doherty GM, Jensen JC, Alexander HR et al. (1991) Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110:192–198
Duh EJ, Maury WJ, Folks TM et al. (1989) Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kB sites in the long terminal repeat. Proc Natl Acad Sci USA 86:5974–5978
Fazley F, Dezube BJ, Allen-Ryan J et al. (1991) Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells. Blood 77:1653–1656
Folks TM, Kessler SW, Orenstein JM et al. (1988) Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 242:919–922
Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203–210
Hardy WD, Hirshaut Y, Hess P (1973) Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence. In: Dutcher RM, Chieco-Bianchi L (eds) Unifying concepts of leukemia. Bibl Haematol 39. S Karger, Basel, pp 778–799
Kawakami TG, Thelien GH, Dungworth DL et al. (1967) “C” type viral particles in the plasma of cats with leukemia. Science 158:1049–1050
Khan KNM, Kociba GJ, Wellman ML et al. (1992a) Cytotoxicity in feline leukemia virus subgroup-C infected fibroblasts is mediated by adherent bone marrow mononuclear cells. In Vitro Cell Dev Biol 28A:260–266
Khan KNM, Kociba GJ, Wellman et al. (1992b) Effects of tumor necrosis factor-α on normal feline hematopoietic progenitor cells. Exp Hematol, 20:900–903
Kociba GJ, Halper JM (1987) Demonstration of retroviral proteins associated with erythroid progenitors of cats with feline leukemia virus-induced erythroid aplasia. Leukemia Res 11:1135–1140
Lahdervirta J, Maury CPJ, Teppo AM (1988) Elevating levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 85:289–91
Martich GD, Danner RL, Ceska M et al. (1991) Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of anti-inflammatory agents. J Exp Med 173:1021–1024
Maury CPJ, Lahdevirta J (1990) Correlation of serum cytokine levels with hematological abnormalities in human immunodeficiency virus infection. J Intern Med 227:253–257
Molina JM, Scadden DT, Byrn R et al. (1989) Production of tumor necrosis factor a and interleukin 1β by monocytic cells infected with human immunodeficiency virus. J Clin Invest 84:733–739
Onions D, Jarrett O, Testa NG et al. (1982) Selective effect of feline leukemia virus on early erythroid progenitors. Nature 296:156–158
Poli G, Kinter A, Justement JS et al. (1990) Tumor necrosis factor a functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 87:782–785
Reddy MH, Sorrell SJ, Lange M et al. (1988) Tumor necrosis factor and HIV p24 antigen levels in serum of HIV-infected populations. J AIDS 1:436–440
Rojko JL, Hoover EA, Mathes LE et al. (1979) Pathogenesis of experimental feline leukemia virus infection. J Natl Cane Inst 63:759–777
Rojko JL, Cheney CM, Gasper PW et al. (1986) Infectious feline leukemia virus is erythrosuppressive in vitro. Leuk Res 10:1193–1199
Roodman GD, Bird A, Hutzler D et al. (1987) Tumor necrosis factoralpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, and HEL cells. Exp Hematol 15:928–935
Sakaguchi T, Hayashi S (1978) Pentoxifylline: Pharmacology and clinical trials of pentoxifylline. Pharmacometrics 15:153–183
Steen PA, Milde JH, Michenfelder JD (1982) Pentoxifylline in regional cerebral ischemia in cats. Acta Anaesth Scand 26:39–43
Strieter RM, Remick DG, Ward PA et al. (1988) Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 155:1230–1236
Ulrich TR, Castillo JD, Yin Songmei (1990) Tumor necrosis factor exerts dose dependent effects on erythropoiesis and myelopoiesis in vivo. Exp Hematol 18:311–315
Ward A, Clissold SP (1987) Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drugs 34:50–97
Watanabe M, Ringler DJ, Nakamura M et al. (1990) Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth. J Virol 64:656–663
Wellman ML, Kociba GJ (1988) Characterization of fibroblast colony forming units in bone marrow from healthy cats. Am J Vet Res 49:231–235
Wellman ML, Kociba GJ, Mathes LE et al. (1984) Inhibition of erythroid colony-forming cells by a Mr 15,000 protein of feline leukemia virus. Cane Res 44:1527–1529
Wellman ML, Kociba GJ, Mathes LE et al. (1988) Suppression of feline bone marrow f broblast colony-forming units by feline leukemia virus. Am J Vet Res 49:227–230
Zack PM, Kociba GJ (1988) Antithymocyte globulin treatment of retroviras-induced feline erythroid aplasia: in vivo and in vitro studies. Clin Immunol Immunopathol 49:390–404
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khan, K.N.M., Kociba, G.J., Wellman, M.L. et al. Tumour necrosis factor-α levels and the effects of pentoxifylline in cats with feline leukaemia virus infection. Comparative Haematology International 2, 133–139 (1992). https://doi.org/10.1007/BF00426166
Issue Date:
DOI: https://doi.org/10.1007/BF00426166